Latvian-American company Exonicus secures €85,000 syndicate investment from LatBAN to expand trauma simulation technology

Exonicus, a Latvian-American company pioneering extended reality (XR) trauma training for defence and emergency medicine, has secured an €85,000 syndicate investment from the Latvian Business Angels Network (LatBAN).

About Exonicus

• Exonicus is a technology company with Latvian roots, founded in 2015 by Sandis Kondrats and Jānis Kondrats with a headquartered in Seattle. It specializes in immersive simulation software aimed at training professionals in various fields, with a focus on healthcare.

• Exonicus’  flagship product – the Exonicus Trauma Simulator – delivers hyperrealistic, AI-powered training scenarios for combat medics, first responders, and healthcare professionals. 

• Used by NATO special operations forces, the U.S. Army, and training centers across Europe, the platform allows real-time simulation of trauma cases in virtual, augmented, and mixed reality formats.

“Exonicus represents the kind of deep-tech ambition we need more of in Latvia – technologies that are exportable, dual-use, and mission-critical. This investment is not just financial; it’s about backing a team that is already shaping the future of trauma simulation in both military and civilian contexts,” says Ansis Spridzāns, Board Member at LatBAN and ASP Asset Management.

Investment details

The round was led by Latvian Business Angels Network (LatBAN) is a leading organization in Latvia that connects private investors (business angels) to support startups and innovative projects at early stages. 

LatBAN helps entrepreneurs raise funding, provides mentorship, and fosters the growth of the startup ecosystem in Latvia and the Baltic region.

The funding is aimed at strengthening Exonicus’ operational capacity as the company finalizes large-scale international military contracts and accelerates market traction in Europe and the United States of America.